FeNO by NIOX USA
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings. The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX is also committed to offering additional training and support for healthcare professionals. Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma. References: 1. Alving K et al. Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO: randomized studies in asthma. Pulm Ther. 2017;3:207-218. 2. Gao J et al. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy, Asthma & Clinical Immunology. 2018;1 3. Busse WW et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021;9(10):1165-1173. 4. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. 5. NIOX. Data on File; MKT-DOF-007.
FeNO by NIOX USA
NIOX Group plc is a company that specialises in the development, manufacture, and distribution of medical devices for the diagnosis and monitoring of asthma. Their flagship product, NIOX VERO, is a non-invasive medical device that measures fractional exhaled nitric oxide (FeNO) levels in patients with asthma. NIOX VERO provides accurate and reliable results, allowing healthcare professionals to make informed decisions about the diagnosis and management of asthma. It is easy to use, and can be used in a variety of settings, including clinics, hospitals, and primary care settings. The NIOX Group plc is committed to improving the lives of people with asthma and is dedicated to innovation and excellence in its products and services. NIOX is also committed to offering additional training and support for healthcare professionals. Overall, NIOX Group plc is the global leader in FeNO testing, with a strong reputation for innovation and excellence in the development of medical devices for the diagnosis and management of asthma. With NIOX VERO, healthcare professionals have a reliable and non-invasive tool to help them better diagnose and manage asthma. References: 1. Alving K et al. Validation of a new portable exhaled nitric oxide analyzer, NIOX VERO: randomized studies in asthma. Pulm Ther. 2017;3:207-218. 2. Gao J et al. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma. Allergy, Asthma & Clinical Immunology. 2018;1 3. Busse WW et al. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Lancet Respir Med. 2021;9(10):1165-1173. 4. Menzies-Gow A et al. Clinical utility of fractional exhaled nitric oxide in severe asthma management. Eur Respir J. 2020;55(3):1901633. 5. NIOX. Data on File; MKT-DOF-007.
niox.com
1100 Perimeter Park Drive Suite 114 Morrisville, North Carolina 27560, US
Details
Year founded
2006
Revenue
25M-75M
Employees
201-500
Number of locations
2
NAICS
3391
SIC
3841
Products & Services
Outlines the company's specialized services and operational strengths.
- FeNO analyzer
- FeNO testing
- NIOX VERO®
- Contact us in order to access
Equipment
Provides a detailed list of machinery and tools utilized on the company's premises.
- NIOX VERO® device for FeNO testing
- Breathing handle with scrubber for NIOX VERO®
- Pre-calibrated sensors for NIOX VERO®
- Contact us in order to access
Ramping up production
Indicates the company's current production trend and growth trajectory.
FALSE
Our production algorithm is showing that feno by niox usa is not ramping up production.
Target industries
Employees working in FeNO by NIOX USA
Locations (2)
FeNO by NIOX USA
1100 Perimeter Park Drive Suite 114 Morrisville, North Carolina 27560, US
Circassia GmbH
Louisenstraße 21, 61348 Bad Homburg vor der Höhe
Frequently Asked Questions
What services & capabilities does FeNO by NIOX USA offer?
FeNO by NIOX USA offers a range of services and capabilities, including FeNO analyzer.
What kind of equipment does FeNO by NIOX USA use?
FeNO by NIOX USA uses a variety of equipment, including NIOX VERO® device for FeNO testing.
What are the target industries of FeNO by NIOX USA?
FeNO by NIOX USA serves several industries, including the medical industry.
How many locations does FeNO by NIOX USA operate?
FeNO by NIOX USA operates from 2 locations.
Where are the headquarters of FeNO by NIOX USA?
The headquarters of FeNO by NIOX USA are located in 1100 perimeter parks drive suite 114, morrisville, north carolina 27560, united states.
What is the NAICS code for FeNO by NIOX USA?
The NAICS code for FeNO by NIOX USA is 3391.
How many employees does FeNO by NIOX USA have?
FeNO by NIOX USA has 206 employees.
What is the official website of FeNO by NIOX USA?
The official website of FeNO by NIOX USA is https://www.niox.com/.
When was FeNO by NIOX USA founded?
FeNO by NIOX USA was founded in 2006.